Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious ...

Reduced commitment into the B-cell lineage is not due to an intrinsic haematopoietic stem cell defect, but likely to a non-permissive bone marrow niche in AAV. Low BAFF-receptor expression on B cells ...

Department of Physiology, State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Basic Medical Sciences and School of Basic Medicine, ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

Lineage, Inc. emphasized its strong operational performance, backed by innovation and strategic capital deployment, while navigating a challenging market environment. The LinOS system and state-of ...

m 6 A RNA modification has been linked to regulation of osteogenic differentiation. This study defines the RNA m 6 A methylome of skeletal cell populations and reveals the role of METTL3-dependent ...

4 Abnormalities in the molecular regulation of Sertoli cell lineage differentiation are involved in DSD: insights into genetic contributions During mammalian embryogenesis, Sertoli cells play a vital ...